Press release
Continuous Blood Glucose Monitoring Systems Market worth $7.79 billion by 2030, growing at a CAGR of 8.12% - Exclusive Report by 360iResearch
Continuous Blood Glucose Monitoring Systems Market | 360iResearch
Request Sample Copy of this Report @ https://www.360iresearch.com/library/intelligence/continuous-blood-glucose-monitoring-systems?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Market Segmentation & Coverage:
This research report categorizes the Continuous Blood Glucose Monitoring Systems Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Product, market is studied across Continuous Glucose Monitoring Systems and Self-Monitoring Blood Glucose Systems. The Continuous Glucose Monitoring Systems is further studied across Receivers, Sensors, and Transmitters. The Self-Monitoring Blood Glucose Systems is further studied across Blood Glucose Meters, Lancets & Lancing Devices, and Testing strips. The Continuous Glucose Monitoring Systems is projected to witness significant market share during forecast period.
Based on Component, market is studied across CGM Monitor, CGM Transmitter, and Glucose Sensor. The CGM Transmitter is projected to witness significant market share during forecast period.
Based on Testing Site, market is studied across Alternate Site Testing and Fingertip Testing. The Fingertip Testing is projected to witness significant market share during forecast period.
Based on Patient Care Setting, market is studied across Hospital & Clinics and Self or Home Care. The Hospital & Clinics is projected to witness significant market share during forecast period.
Based on Application, market is studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes. The Gestational Diabetes is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Continuous Blood Glucose Monitoring Systems Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Continuous Blood Glucose Monitoring Systems Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Continuous Blood Glucose Monitoring Systems Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l., Abbott Laboratories, B. Braun Melsungen AG, Dexcom, Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, GlySens Incorporated, Johnson & Johnson Services, Inc., LifeScan IP Holdings, LLC, Medtronic PLC, Novo Nordisk A/S, OrSense Ltd., PHC Holdings Corporation, Senseonics Holdings, Inc., and Tandem Diabetes Care, Inc..
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Continuous Blood Glucose Monitoring Systems Market, by Product
7. Continuous Blood Glucose Monitoring Systems Market, by Component
8. Continuous Blood Glucose Monitoring Systems Market, by Testing Site
9. Continuous Blood Glucose Monitoring Systems Market, by Patient Care Setting
10. Continuous Blood Glucose Monitoring Systems Market, by Application
11. Americas Continuous Blood Glucose Monitoring Systems Market
12. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market
13. Europe, Middle East & Africa Continuous Blood Glucose Monitoring Systems Market
14. Competitive Landscape
15. Competitive Portfolio
16. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Continuous Blood Glucose Monitoring Systems Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Continuous Blood Glucose Monitoring Systems Market?
3. What is the competitive strategic window for opportunities in the Continuous Blood Glucose Monitoring Systems Market?
4. What are the technology trends and regulatory frameworks in the Continuous Blood Glucose Monitoring Systems Market?
5. What is the market share of the leading vendors in the Continuous Blood Glucose Monitoring Systems Market?
6. What modes and strategic moves are considered suitable for entering the Continuous Blood Glucose Monitoring Systems Market?
Read More @ https://www.360iresearch.com/library/intelligence/continuous-blood-glucose-monitoring-systems?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Continuous Blood Glucose Monitoring Systems Market worth $7.79 billion by 2030, growing at a CAGR of 8.12% - Exclusive Report by 360iResearch here
News-ID: 3237729 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Glucose
Glucose Syrup And Glucose Fructose Syrup Market Size by Application, Type, Geogr …
USA, New Jersey- According to Market Research Intellect, the global Glucose Syrup And Glucose Fructose Syrup market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The glucose syrup and glucose fructose syrup market is witnessing consistent growth due to their widespread use across the food and…
Industrial Glucose Market Is Driven By Industrial Glucose In Various Industries, …
Industrial glucose, also known as dextrose, serves as a vital ingredient across various industries, including food and beverage, pharmaceuticals, cosmetics, and the production of biofuels. This versatile sweetener and carbohydrate source play a fundamental role in manufacturing processes. The global industrial glucose market has witnessed significant growth, driven by key drivers and marked by noteworthy trends that are reshaping its applications and demand across industries.
Download Free PDF Sample Report @https://www.globalinsightservices.com/request-sample/GIS25657/?utm_source=OpenPR-Sneha&utm_medium=industrial-glucose-market
Key…
Continuous-Blood Glucose Monitoring Market - Continuous Monitoring, Embracing St …
Newark, New Castle, USA - new report, titled Continuous-Blood Glucose Monitoring Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Continuous-Blood Glucose Monitoring market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Continuous-Blood Glucose Monitoring market. The report offers an overview of…
Glucose Elevating Agents Market - Elevate Control, Empower Health: Innovations i …
Newark, New Castle, USA - new report, titled Glucose Elevating Agents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Glucose Elevating Agents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Glucose Elevating Agents market. The report offers an overview of…
Blood Glucose Monitoring Market analysis report- with Leading players, Applicati …
Blood Glucose Monitoring Market
The Global Blood Glucose Monitoring Market is defined by the presence of some of the leading competitors operating in the market, including the well-established players and new entrants, and the suppliers, vendors, and distributors. One of the main aims of diabetes treatment is to keep blood glucose levels within a specified target range. The key is balancing your food with your activity, lifestyle and diabetes medicines. Blood glucose monitoring…
Asia Pacific Blood Glucose Monitoring Market by Product Type, Invasive Glucose M …
Asia Pacific Blood Glucose Monitoring Market - Overview
Blood glucose monitoring is the process of testing the glucose level in the blood. It helps to identify the blood glucose level within the specified target range. Thus, it helps to understand the food intake, exercise, insulin, and blood glucose level. The blood glucose monitoring devices provide useful information to manage diabetes. It helps to track the progress of treatment goal as well…
